Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices

Catheterization and Cardiovascular Interventions

Volumn 48, Issue 2, 1999, Pages 123-129

  Kini, Annapoorna ^a   Kini, Subhash ^a   Marmur, Jonathan D ^a   Bertea, Tudor ^a   Dangas, George ^a   Cocke, Thomas P ^a   Sharma, Samin K ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Abciximab; Angioplasty; CK MB isoenzyme; Coronary intervention; New devices

Indexed keywords

ABCIXIMAB; CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; ENZYME RELEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SURGICAL RISK; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ATHERECTOMY, CORONARY; CORONARY DISEASE; CREATINE KINASE; EQUIPMENT DESIGN; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS; STENTS;

EID: 0032837104     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199910)48:2<123::AID-CCD1>3.0.CO;2-O     Document Type: Article

References (24)

1. Pauletto P, Piccolo D, Scannapieco G, Vescovo G, Zaninotto M, Corbara F, Cuman G, Chioin R, Casiglia E, Maddalena F, Pessina A, Dal Pallu C. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal angioplasty for stable angina pectoris. Am J Cardiol 1987;59:999-1006.
2. Ravkilde J, Nissen H, Mickley H, Andersen P, Thayssen P, Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994;127:13-20.
3. Chaitman B, Jaffe A. What is the true periprocedure myocardial infarction rate? does anyone know for sure? the need for clarification. Circulation 1995;91:1609-1610.
4. Califf R, Abdelmeguid A, Kuntz R, Popma J, Davidson C, Cohen E, Kleiman N, Mahaffey K, Topol E, Pepine C, Lipicky R, Granger C, Harrington R, Tardiff B, Crenshaw B, Bauman R, Zuckerman B, Chaitman B, Bittl J, Ohman E. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251.
5. Klein L, Kramer B, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q-wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 1991;17:621-626.
6. Kong Q, Davidson C, Meyers N, Tauke J, Parker M, Bonow R. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997;277:461-466.
7. Abdelmeguid A, Topol E, Whitlow P, Sapp S, Ellis S. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-1536
8. Kugelmass A, Cohen C, Moscucci M, Piana R, Senerchia C, Kuntz R, Baim D. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994;74:748-754.
9. Cutlip D, Chauhan M, Senerchia C, Ho K, Baim D, Kuntz R. Influence of myocardial infarction following otherwise successful coronary intervention on late mortality. Circulation 1997;96(suppl I):I30.
10. Saucedo J, Popma J, Mehran R, Bucher T, Abizaid A, Curran M, Mastoor M, Kent K, Pichard A, Satler L, Leon M. Lack of association of intermediate CPK-MB elevation and late mortality in patients treated with intracoronary stent. J Am Coll Cardiol 1998;31(suppl A):215A.
11. Detre K, Holmes D, Holubkov R, Cowley M, Bourassa M, Faxon D, Dorros G, Bentivoglio L, Kent K, Myler R. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1990;82:739-750.
12. Kong T, Meyers S, Parker M, Elliot M, Davidson C. Predictors and late sequelae of distal embolization in patients with creatine kinase elevation following elective PTCA. J Am Coll Cardiol 1996: 27(suppl A):360A.
13. Adams J, Abendschein D, Jaffe A. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993;88:750-763.
14. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
15. George B. Theoretical and clinical aspects of slow flow and no-reflow phenomenon. J Invas Cardiol 1996;8(suppl C):10C-15C.
16. Harrington R, Lincoff A, Califf R, Holmes D, Berdan L, O'Hanesian M, Keeler G, Garrat K, Ohman E, Mark D, Jacobs A, Topol E. Characteristics and consequences of myocardial infarction after percutaneous coronary interventions: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVAET). J Am Coll Cardiol 1995;25:1693-1699.
17. Reifart N, Vandormael M, Krajcar M, Göhring S, Preusler W, Schwarz F, Störger F, Hofmann M, Klöpper J, Müller S, Haase J. Randomized comparison of angioplasty of complex coronary lesions at a single center-excimer laser, rotational atherectomy and balloon angioplasty comparison (ERBAC) study. Circulation 1998; 96:91-98.
18. Baim D, Cutlip D, Sharma S, Ho K, Fortuna R, Schreiber T, Feldman R, Shani J, Senerchia C, Zhang Y, Lansky A, Popma J, Kuntz R. Final results of the balloon vs. optimal atherectomy trial (BOAT). Circulation 1998;97:322-328.
19. Sharma S, Kini A, Kini S, Vidhun R, Dangas G, Duvvuri S, Cocke T, Marmur J, Ambrose J. Creatine kinase-MB enzyme elevation after coronary intervention with different devices. J Am Coll Cardiol 1998;31(suppl A):215A.
20. Kini A, Marmur J, Duvvuri S, Dangas G, Choudhary S, Sharma S. Rotational atherectomy: improved procedural outcome with evolution of technique and equipment. Cathet Cardiovasc Intervent 1999;46:305-311.
21. Sharma S, Dangas G, Mehran R, Duvvuri S, Kini A, Cocke T, Kakarala V, Cohen A, Marmur J, Ambrose J. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol 1997;80:219-222.
22. Ellis S, Popma J, Buchbinder M, Franco I, Leon M, Kent K, Pichard A, Satler L, Topol E, Whitlow P. Relation of clinical presentaation, stenosis, morphology and operator technique to the procedural results of rotational atherectomy and rotational atherectomy facilitated angioplasty. Circulation 1994;89:882-892.
23. Aliabadi D, Tilli F, Bowers T, Benzuly K, Safian R, Goldstein J, Grines C, O'Neill W. Incidence and angiographic predictors following high pressure intracoronary stenting. Am J Cardiol 1997;80:994-997.
24. Ohman E, Califf R, Topol E. Cardiac troponins in acute coronary syndromes. N Engl J Med 1997;336:1257-1259.